| Product Code: ETC12836110 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Infectious Vaccines Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Infectious Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Infectious Vaccines Market - Industry Life Cycle |
3.4 Canada Infectious Vaccines Market - Porter's Five Forces |
3.5 Canada Infectious Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Canada Infectious Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Canada Infectious Vaccines Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
3.8 Canada Infectious Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Infectious Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Canada |
4.2.2 Government initiatives to improve vaccination rates |
4.2.3 Technological advancements in vaccine development and production |
4.3 Market Restraints |
4.3.1 Vaccine hesitancy and misinformation |
4.3.2 High costs associated with vaccine research and development |
4.3.3 Regulatory challenges in vaccine approval processes |
5 Canada Infectious Vaccines Market Trends |
6 Canada Infectious Vaccines Market, By Types |
6.1 Canada Infectious Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Canada Infectious Vaccines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Canada Infectious Vaccines Market Revenues & Volume, By Live Attenuated Vaccines, 2021 - 2031F |
6.1.4 Canada Infectious Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021 - 2031F |
6.1.5 Canada Infectious Vaccines Market Revenues & Volume, By mRNA Vaccines, 2021 - 2031F |
6.2 Canada Infectious Vaccines Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Canada Infectious Vaccines Market Revenues & Volume, By COVID-19, 2021 - 2031F |
6.2.3 Canada Infectious Vaccines Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.4 Canada Infectious Vaccines Market Revenues & Volume, By Hepatitis, 2021 - 2031F |
6.3 Canada Infectious Vaccines Market, By End-Use |
6.3.1 Overview and Analysis |
6.3.2 Canada Infectious Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Canada Infectious Vaccines Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.3.4 Canada Infectious Vaccines Market Revenues & Volume, By Government Immunization Programs, 2021 - 2031F |
6.4 Canada Infectious Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Canada Infectious Vaccines Market Revenues & Volume, By Public Health Agencies, 2021 - 2031F |
6.4.3 Canada Infectious Vaccines Market Revenues & Volume, By Private Clinics, 2021 - 2031F |
7 Canada Infectious Vaccines Market Import-Export Trade Statistics |
7.1 Canada Infectious Vaccines Market Export to Major Countries |
7.2 Canada Infectious Vaccines Market Imports from Major Countries |
8 Canada Infectious Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rates among different age groups |
8.2 Number of vaccine doses administered annually |
8.3 Research and development investment in new vaccine technologies |
9 Canada Infectious Vaccines Market - Opportunity Assessment |
9.1 Canada Infectious Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Canada Infectious Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Canada Infectious Vaccines Market Opportunity Assessment, By End-Use, 2021 & 2031F |
9.4 Canada Infectious Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Infectious Vaccines Market - Competitive Landscape |
10.1 Canada Infectious Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Canada Infectious Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here